Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H24N2O3.ClH |
| Molecular Weight | 316.824 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCNC(=O)COC1=CC=C(OC)C=C1
InChI
InChIKey=AXBHPHPHZHAOAK-UHFFFAOYSA-N
InChI=1S/C15H24N2O3.ClH/c1-4-17(5-2)11-10-16-15(18)12-20-14-8-6-13(19-3)7-9-14;/h6-9H,4-5,10-12H2,1-3H3,(H,16,18);1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Further study and the comparative characteristics of potential stimulants of higher nervous activity]. | 1982-09-01 |
|
| Mefexamide as an antiparkinson drug. (A double-blind study). | 1969-04 |
|
| [Clinical trial with a new antidepressive and anti-asthenia drug; Mefexamide]. | 1967-04-05 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3083802
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY | |||
|
DTXSID2045862
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY | |||
|
m811
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
M00ED8AW1S
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY | |||
|
3413-64-7
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY | |||
|
222-304-4
Created by
admin on Mon Mar 31 21:33:01 GMT 2025 , Edited by admin on Mon Mar 31 21:33:01 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD